acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution

RxCUI: 1236070
RxNorm name: acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution
Term type: SCD
Status: Active
Updated: 2026-07-18 07:01:19

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 022012
Active start: 022012
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
acetaminophen	21.7 MG / 1 ML	acetaminophen	acetaminophen
chlorpheniramine maleate	0.13 MG / 1 ML	chlorpheniramine	chlorpheniramine maleate
dextromethorphan hydrobromide	0.67 MG / 1 ML	dextromethorphan	dextromethorphan hydrobromide

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Solution	316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
acetaminophen	161
chlorpheniramine	2400
dextromethorphan	3289

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
RXNAV_STR	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution	NAMES
RxNorm Name	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution	NAMES
RxNorm Synonym	APAP 21.7 MG/ML / Chlorpheniramine Maleate 0.13 MG/ML / Dextromethorphan Hydrobromide 0.67 MG/ML Oral Solution	NAMES
RxNorm Synonym	APAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 15 ML Oral Solution	NAMES
TTY	SCD	ATTRIBUTES
SPL_SET_ID	18f3d694-9dff-407e-a264-916dbd201f9a	CODES
RxCUI	1236070	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
49873-108-01	49873-108	Stona for Children acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide	Sato Pharmaceutical Co., Ltd.	M012

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
M012	49873-108	Stona for Children acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide	OTC MONOGRAPH DRUG	Sato Pharmaceutical Co., Ltd.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11	Source	Active
49873010801	rxnav_ndcs	yes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
18f3d694-9dff-407e-a264-916dbd201f9a	APAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 15 ML Oral Solution	SY	6	Stona Syrup for Children (PLD/MFR)	20250119
18f3d694-9dff-407e-a264-916dbd201f9a	acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution	PSN	6	Stona Syrup for Children (PLD/MFR)	20250119
18f3d694-9dff-407e-a264-916dbd201f9a	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution	SCD	6	Stona Syrup for Children (PLD/MFR)	20250119
18f3d694-9dff-407e-a264-916dbd201f9a	APAP 21.7 MG/ML / Chlorpheniramine Maleate 0.13 MG/ML / Dextromethorphan Hydrobromide 0.67 MG/ML Oral Solution	SY	6	Stona Syrup for Children (PLD/MFR)	20250119

DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
18f3d694-9dff-407e-a264-916dbd201f9a	Stona Syrup for Children (PLD/MFR)	Sato Pharmaceutical Co., Ltd. \| Fuji Seal, Inc.	20250119

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N02BE	Anilides	ATC1-4		acetaminophen
ATC	R05DA	Opium alkaloids and derivatives	ATC1-4		dextromethorphan
ATC	R06AB	Substituted alkylamines	ATC1-4		chlorpheniramine
FDASPL	N0000175587	Histamine-1 Receptor Antagonist	EPC	has_epc	chlorpheniramine
FDASPL	N0000182149	Sigma-1 Agonist	EPC	has_epc	dextromethorphan
FDASPL	N0000181821	Uncompetitive N-methyl-D-aspartate Receptor Antagonist	EPC	has_epc	dextromethorphan
FDASPL	N0000182147	Sigma-1 Receptor Agonists	MOA	has_moa	dextromethorphan
FDASPL	N0000181819	Uncompetitive NMDA Receptor Antagonists	MOA	has_moa	dextromethorphan
MEDRT	D000082	Acetaminophen	CHEM	has_ingredient	acetaminophen
MEDRT	D002744	Chlorpheniramine	CHEM	has_ingredient	chlorpheniramine maleate
MEDRT	D002744	Chlorpheniramine	CHEM	has_ingredient	chlorpheniramine
MEDRT	D003915	Dextromethorphan	CHEM	has_ingredient	dextromethorphan hydrobromide
MEDRT	D003915	Dextromethorphan	CHEM	has_ingredient	dextromethorphan
MEDRT	D003371	Cough	DISEASE	may_treat	dextromethorphan hydrobromide
MEDRT	D003371	Cough	DISEASE	may_treat	dextromethorphan
MEDRT	D003371	Cough	DISEASE	may_prevent	dextromethorphan
MEDRT	D003371	Cough	DISEASE	may_prevent	dextromethorphan hydrobromide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	dextromethorphan hydrobromide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	dextromethorphan
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	chlorpheniramine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	acetaminophen
MEDRT	D004380	Duodenal Obstruction	DISEASE	ci_with	chlorpheniramine
MEDRT	D004380	Duodenal Obstruction	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D005334	Fever	DISEASE	may_prevent	acetaminophen
MEDRT	D005334	Fever	DISEASE	may_treat	acetaminophen
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	chlorpheniramine
MEDRT	D005955	Glucosephosphate Dehydrogenase Deficiency	DISEASE	ci_with	acetaminophen
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	chlorpheniramine
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D007234	Infant, Premature	DISEASE	ci_with	chlorpheniramine
MEDRT	D007234	Infant, Premature	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	acetaminophen
MEDRT	D010146	Pain	DISEASE	may_prevent	acetaminophen
MEDRT	D010146	Pain	DISEASE	may_treat	acetaminophen
MEDRT	D010437	Peptic Ulcer	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D010437	Peptic Ulcer	DISEASE	ci_with	chlorpheniramine
MEDRT	D011470	Prostatic Hyperplasia	DISEASE	ci_with	chlorpheniramine
MEDRT	D011470	Prostatic Hyperplasia	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	chlorpheniramine maleate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	chlorpheniramine
MEDRT	D013224	Status Asthmaticus	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D013224	Status Asthmaticus	DISEASE	ci_with	chlorpheniramine
MEDRT	D001748	Urinary Bladder Neck Obstruction	DISEASE	ci_with	chlorpheniramine
MEDRT	D001748	Urinary Bladder Neck Obstruction	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D014581	Urticaria	DISEASE	may_treat	chlorpheniramine maleate
MEDRT	D014581	Urticaria	DISEASE	may_treat	chlorpheniramine
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	chlorpheniramine maleate
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	chlorpheniramine
MEDRT	N0000000184	Monoamine Oxidase Inhibitors	MOA	ci_moa	dextromethorphan
MEDRT	N0000000184	Monoamine Oxidase Inhibitors	MOA	ci_moa	dextromethorphan hydrobromide
MEDRT	N0000000108	Prostaglandin Receptor Antagonists	MOA	has_moa	acetaminophen
MEDRT	N0000000109	Serotonin Uptake Inhibitors	MOA	has_moa	dextromethorphan hydrobromide
MEDRT	N0000000109	Serotonin Uptake Inhibitors	MOA	has_moa	dextromethorphan
MEDRT	N0000182147	Sigma-1 Receptor Agonists	MOA	has_moa	dextromethorphan
MEDRT	N0000182147	Sigma-1 Receptor Agonists	MOA	has_moa	dextromethorphan hydrobromide
MEDRT	N0000181819	Uncompetitive NMDA Receptor Antagonists	MOA	has_moa	dextromethorphan
MEDRT	N0000181819	Uncompetitive NMDA Receptor Antagonists	MOA	has_moa	dextromethorphan hydrobromide
MEDRT	N0000175724	Central Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	chlorpheniramine maleate
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	chlorpheniramine
MEDRT	N0000008701	Decreased Medullary Respiratory Drive	PE	has_pe	dextromethorphan
MEDRT	N0000008701	Decreased Medullary Respiratory Drive	PE	has_pe	dextromethorphan hydrobromide
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	acetaminophen
MEDRT	N0000009072	Hypothalamic Endocrine Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000175725	Peripheral Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	acetaminophen
MEDRT	N0000000042	Renal Excretion	PK	has_pk	acetaminophen

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Oral Solution	rxnav_allrelated
DFG	DFG	Oral Liquid Product	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	acetaminophen	rxnav_allrelated
IN	IN	chlorpheniramine	rxnav_allrelated
IN	IN	dextromethorphan	rxnav_allrelated
MIN	MIN	acetaminophen / chlorpheniramine / dextromethorphan	rxnav_allrelated
PIN	PIN	chlorpheniramine maleate	rxnav_allrelated
PIN	PIN	dextromethorphan hydrobromide	rxnav_allrelated
SCD	SCD	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution	rxnav_allrelated
SCDC	SCDC	acetaminophen 21.7 MG/ML	rxnav_allrelated
SCDC	SCDC	chlorpheniramine maleate 0.13 MG/ML	rxnav_allrelated
SCDC	SCDC	dextromethorphan hydrobromide 0.67 MG/ML	rxnav_allrelated
SCDF	SCDF	acetaminophen / chlorpheniramine / dextromethorphan Oral Solution	rxnav_allrelated
SCDFP	SCDFP	acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution	rxnav_allrelated
SCDG	SCDG	acetaminophen / chlorpheniramine / dextromethorphan Oral Liquid Product	rxnav_allrelated
SCDG	SCDG	acetaminophen / chlorpheniramine / dextromethorphan Oral Product	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Liquid Product	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	21.7 MG/ML / 0.13 MG/ML / 0.67 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	TTY	SCD
CODES	RxCUI	1236070
CODES	SPL_SET_ID	18f3d694-9dff-407e-a264-916dbd201f9a
NAMES	Prescribable Synonym	acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution
NAMES	RXNAV_STR	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution
NAMES	RxNorm Name	acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution
NAMES	RxNorm Synonym	APAP 21.7 MG/ML / Chlorpheniramine Maleate 0.13 MG/ML / Dextromethorphan Hydrobromide 0.67 MG/ML Oral Solution
NAMES	RxNorm Synonym	APAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 15 ML Oral Solution
SOURCES	Source	Metathesaurus FDA Structured Product Labels

acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution

RxNorm Status History#

Ingredients And Strength#

Dose Form Concepts#

Derived Ingredient Concepts#

Source Vocabulary Codes#

FDA NDC Products And Packages#

Drugs@FDA Applications#

RxNav Current And Historical NDCs#

DailyMed RxNorm Mappings#

DailyMed Labels#

Drug Classes#

Related Concepts#

Properties#